Immunotherapy for multiple myeloma: new chances and hope

被引：0
|
作者：
Jingyu Xu [1 ,2 ]
Gang An [1 ,2 ]
Lugui Qiu [1 ,2 ]
机构：
[1] State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
[2] Tianjin Institutes of Health Science
来源：
Cancer Biology & Medicine | 2023年 / 10期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R733.3 [骨髓肿瘤];
学科分类号：
100214 ;
摘要：
Introduction Multiple myeloma(MM), characterized by the proliferation of monoclonal plasma cells in the bone marrow, has the second highest incidence among hematologic malignancies1. Because of its incurable nature, treatments for MM are aimed primarily at obtaining minimal residual disease(MRD) negativity and achieving persistent control, both of which are believed to be important strategies to prolong survival and improve prognosis in patients with MM.
引用
收藏
页码：695 / 700
页数：6
相关论文
共 50 条
  • [41] BCMA Offers Hope in Multiple Myeloma
    Hennessy, Mike, Sr.
    ONCOLOGY-NEW YORK, 2020, 34 (11): : 458 - 458
  • [42] Immunotherapy: new hype or hope?
    Weller, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E484 - E484
  • [43] Immunotherapy in polysensitized patients: new chances for the allergists?
    Ciprandi, Giorgio
    Melioli, Giovanni
    Passalacqua, Giovanni
    Canonica, Giorgio Walter
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (06) : 392 - 394
  • [44] IMMUNOTHERAPY IN MULTIPLE MYELOMA: EXPERIENCE OF THE MULTIPLE MYELOMA GIMEMA LAZIO GROUP
    Vozella, F.
    Siniscalchi, A.
    Rizzo, M.
    Za, T.
    Antolino, G.
    Coppetelli, U.
    Piciocchi, A.
    Andriani, A.
    Annibali, O.
    De Rosa, L.
    Cimino, G.
    La Verde, G.
    De Stefano, V.
    Cantonetti, M.
    di Toritto, T. Caravita
    Foa, R.
    Petrucci, M. T.
    HAEMATOLOGICA, 2019, 104 : 117 - 117
  • [45] Immunotherapy in Multiple Myeloma: Experience of the Multiple Myeloma Gimema Lazio Group
    Vozella, Federico
    Siniscalchi, Agostina
    Rizzo, Manuela
    Za, Tommaso
    Antolino, Giusy
    Coppetelli, Ugo
    Piciocchi, Alfonso
    Andriani, Alessandro
    Annibali, Ombretta
    De Rosa, Luca
    Cimino, Giuseppe
    La Verde, Giacinto
    De Stefano, Valerio
    Cantonetti, Maria
    di Toritto, Tommaso Caravita
    Foa, Robin
    Petrucci, Maria Teresa
    BLOOD, 2018, 132
  • [46] Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs
    Festuccia, Moreno
    Martino, Massimo
    Ferrando, Federica
    Messina, Giuseppe
    Moscato, Tiziana
    Fedele, Roberta
    Boccadoro, Mario
    Giaccone, Luisa
    Bruno, Benedetto
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (06) : 857 - 872
  • [47] Recent advances in multiple myeloma immunotherapy
    Ruffini, PA
    Biragyn, A
    Kwak, LW
    BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (03) : 129 - 132
  • [48] Talquetamab: A promising immunotherapy for multiple myeloma
    Tariq, Amna
    Wahid, Abdul
    Asif, Fatima
    Khan, Mahnoor
    RARE TUMORS, 2023, 15
  • [49] Immunotherapy of Multiple Myeloma: Promise and Challenges
    Abramson, Hanley N.
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 343 - 371
  • [50] Cellular and vaccine immunotherapy for multiple myeloma
    Garfall, Alfred L.
    Stadtmauer, Edward A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 521 - 527
12345